3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine has been researched along with quinine in 1 studies
Studies (3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine) | Trials (3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine) | Recent Studies (post-2010) (3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine) | Studies (quinine) | Trials (quinine) | Recent Studies (post-2010) (quinine) |
---|---|---|---|---|---|
5 | 0 | 1 | 6,859 | 398 | 1,099 |
Protein | Taxonomy | 3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine (IC50) | quinine (IC50) |
---|---|---|---|
Solute carrier family 22 member 1 | Mus musculus (house mouse) | 0.28 | |
Solute carrier family 22 member 2 | Mus musculus (house mouse) | 2.8 | |
Potassium channel subfamily K member 2 | Homo sapiens (human) | 3.85 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.7 | |
Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | 0.094 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.6285 | |
Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | 2.0333 | |
Cytochrome P450 2D4 | Rattus norvegicus (Norway rat) | 1.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abramcheck, FJ; Helman, SI; Van Driessche, W | 1 |
1 other study(ies) available for 3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine and quinine
Article | Year |
---|---|
Autoregulation of apical membrane Na+ permeability of tight epithelia. Noise analysis with amiloride and CGS 4270.
Topics: Amiloride; Animals; Cell Membrane Permeability; Electricity; Epithelium; Homeostasis; Ion Channels; Physiology; Pyrazines; Quinidine; Quinine; Rana pipiens; Skin; Sodium | 1985 |